RavenQuest BioMed Inc. (RVVQF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -11.1 Million | -2.51 Million | -32.44 Thousand | -19.71 Thousand | -36.62 Thousand | -40.95 Thousand |
| Net Income | -30.46 Million | -3.3 Million | -81.45 Thousand | -76.02 Thousand | -60.56 Thousand | -502.22 Thousand |
| Depreciation & Amortization | 1.88 Million | 286.00 | - | - | - | - |
| Deferred income taxes | -578 Thousand | 2.38 Million | - | - | - | - |
| Stock-based compensation | 6.15 Million | 45.8 Thousand | - | - | - | - |
| Change in working capital | -1.96 Million | -1.64 Million | 49.01 Thousand | 56.31 Thousand | 23.94 Thousand | 64.16 Thousand |
| Other non-cash items | 13.86 Million | 2.38 Million | - | 1.00 | - | 397.1 Thousand |
| Investing Cash Flow | -28.54 Million | -158.61 Thousand | - | - | 33.88 Thousand | 5824.00 |
| Investments in PPE | -12.25 Million | -952.00 | - | - | - | 5824.00 |
| Acquisitions | -16.28 Million | -157.65 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 33.88 Thousand | - |
| Financing Cash Flow | 36.62 Million | 6.04 Million | 31.52 Thousand | 11.84 Thousand | 11.1 Thousand | 29.15 Thousand |
| Debt repayment | -200 Thousand | -820.53 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 19.76 Million | 6.3 Million | - | - | - | - |
| Other Financing Activities | 17.06 Million | 568.82 Thousand | - | 11.84 Thousand | 11.1 Thousand | 29.15 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | 60.12 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.96 Million | - | - | - | - | 4034.00 |
| Cash at beginning of period | 3.37 Million | 604.00 | 1526.00 | 9393.00 | 1026.00 | 7006.00 |
| Cash at end of period | 362.81 Thousand | 3.37 Million | 604.00 | 1526.00 | 9393.00 | 1026.00 |
| Capital Expenditure | -12.25 Million | -952.00 | - | - | - | 5824.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -3.01 Million | 3.37 Million | -922.00 | -7867.00 | 8367.00 | -5980.00 |
| Free Cash Flow | -23.36 Million | -2.51 Million | -32.44 Thousand | -19.71 Thousand | -36.62 Thousand | -35.13 Thousand |
| Breakdown | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 FY | 2018 Q4 | 2018 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.12 Million | -3.2 Million | -3.19 Million | -30.46 Million | -22.82 Million | -3.18 Million |
| Depreciation & Amortization | 803.73 Thousand | 480.94 Thousand | 770.93 Thousand | 1.88 Million | 1.83 Million | 37.16 Thousand |
| Deferred income taxes | -156.12 Thousand | -348.00 | 474.00 | -578 Thousand | 11.37 Million | - |
| Stock-based compensation | 830.44 Thousand | 183.94 Thousand | 896.14 Thousand | 6.15 Million | 4.42 Million | 364.74 Thousand |
| Change in working capital | -503.38 Thousand | 140.49 Thousand | 2.66 Million | -1.96 Million | 3.86 Million | -4.16 Million |
| Other non-cash items | 555.36 Thousand | 1.52 Million | 391.82 Thousand | 13.86 Million | 12.53 Million | 707.53 Thousand |
| Investing Cash Flow | -655.07 Thousand | -1.5 Million | -1.67 Million | -28.54 Million | -3.96 Million | -5.43 Million |
| Investments in PPE | -655.07 Thousand | -1.5 Million | -1.67 Million | -12.25 Million | -3.33 Million | -5.43 Million |
| Acquisitions | - | - | - | -16.28 Million | -630.55 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.53 Million | 2.72 Million | 745.02 Thousand | 36.62 Million | 3.12 Million | 7.77 Million |
| Debt repayment | - | - | -200 Thousand | -200 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.52 Million | - | - | 19.76 Million | - | 8.32 Million |
| Other Financing Activities | -985.19 Thousand | 2.72 Million | 945.02 Thousand | 17.06 Million | 3.12 Million | -553.1 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | 140.49 Thousand | 2.66 Million | -1.96 Million | - | - |
| Cash at beginning of period | 1.3 Million | 955.87 Thousand | 362.81 Thousand | 3.37 Million | 1.36 Million | 5.25 Million |
| Cash at end of period | 749.13 Thousand | 1.3 Million | 955.87 Thousand | 362.81 Thousand | 362.81 Thousand | 1.36 Million |
| Capital Expenditure | -655.07 Thousand | -1.5 Million | -1.67 Million | -12.25 Million | -3.33 Million | -5.43 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -554.63 Thousand | 347.89 Thousand | 593.06 Thousand | -3.01 Million | -999.06 Thousand | -3.89 Million |
| Free Cash Flow | -2.09 Million | -2.37 Million | -151.96 Thousand | -23.36 Million | -3.48 Million | -11.67 Million |
CSGQF
BAER
688386
9566
AJ91
ETM